Skip to main content

How to Reorder Your Medication

How to reorder your GLP-1 medication through the Bliv patient portal, when to reorder, and what happens after you submit your request.

Written by Holley

📋 About Your Medication
Bliv offers both compounded GLP-1 medications prepared by licensed compounding pharmacies, and access to branded GLP-1 medications manufactured by Novo Nordisk (Ozempic®, Wegovy®) and Eli Lilly (Mounjaro®, Zepbound®). Your prescription will specify which type you have been prescribed. Compounded medications are not FDA-approved finished drug products, though they are prepared under federal standards by licensed pharmacies. Branded medications are FDA-approved. If you have questions about which medication you are receiving, please check your prescription label or contact your Bliv provider.


Reordering Through Your Patient Portal

The fastest way to reorder your medication is through your Bliv patient portal at app.joinbliv.com/login. Log in, navigate to your prescriptions, and follow the prompts to submit a reorder request. Your provider will review and approve it, after which the pharmacy will process and ship your next supply.

When to Reorder

Reorder before your current supply runs out — not after. Your dosing plan includes an estimated end date for your current supply. Plan ahead to allow time for prescription approval and shipping.

What Happens After You Submit a Reorder

  1. Provider review: Your Bliv provider reviews your reorder request.

  2. Pharmacy processing: Once approved, the prescription is sent to the pharmacy for preparation.

  3. Shipping: Your order is shipped with a tracking number sent to your email.

Changing Your Dose at Reorder

If you want to change your dose when reordering, note this in your reorder request through the portal, or contact support before reordering. Your provider will take that into account during their review.

Can't Log In?

Visit app.joinbliv.com/login and use the password reset option. Or contact [email protected].

Did this answer your question?